Taylor-Rowan, MartinEdwards, SophieNoel-Storr, Anna HMcCleery, JennyMyint, Phyo KSoiza, RoyStewart, CarrieLoke, Yoon KongQuinn, Terry J2022-05-042022-05-042021-05-05Taylor-Rowan, M, Edwards, S, Noel-Storr, A H, McCleery, J, Myint, P K, Soiza, R, Stewart, C, Loke, Y K & Quinn, T J 2021, 'Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome (Review)', Cochrane Database of Systematic Reviews, vol. 5, no. 4, CD013540. https://doi.org/10.1002/14651858.CD013540.pub21469-493XORCID: /0000-0002-1397-4272/work/93483007ORCID: /0000-0003-3852-6158/work/163198923https://hdl.handle.net/2164/18521Funding Information: National Institute on Aging, NIH Grants, and the Branta Foundation Funding Information: We followed best practice in design, conduct, and reporting of our prognosis review as detailed in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2019). The review was supported by the Cochrane Prognostic Methods Group, partners within the Cochrane Mental Health and Neuroscience Network, and the UK National Institute for Health Research Complex Reviews Support Unit (NIHR CRSU). Funding Information: American Philosophical Society, the National Institute on Aging grants, and by the Illinois Department of Public Health to DAB Funding Information: This protocol was supported by the National Institute for Health Research (NIHR), via Cochrane Infrastructure funding to the Cochrane Dementia and Cognitive Improvement group. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, National Health Service or the Department of Health Publisher Copyright: Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.711433704engR MedicineSupplementary DataRJournal article10.1002/14651858.CD013540.pub2http://www.scopus.com/inward/record.url?scp=85105467209&partnerID=8YFLogxK54